Why Saudi Arabia’s preventive health push is both a moral and financial win 
Saudi Arabia is undergoing one of the most ambitious healthcare transformations in the world.
Over the past decade, the Kingdom has invested heavily in expanding healthcare access, modernizing infrastructure and improving clinical outcomes.
Yet perhaps the most important shift underway is not happening in hospitals at all. It is taking place much earlier before illness develops, before chronic disease takes hold and before healthcare costs begin to escalate.
The increasing focus on prevention is becoming a defining feature of the Kingdom’s Health Sector Transformation Program under Vision 2030.
It reflects a growing recognition that the most effective healthcare systems are not those that simply treat disease well, but those that prevent it in the first place.
For Saudi Arabia, this is both a moral imperative and a strategic economic opportunity.
The case for prevention has never been stronger. Globally, non-communicable diseases such as cardiovascular disease, diabetes, cancer and chronic respiratory conditions account for roughly three-quarters of all deaths, according to the World Health Organization.
Yet despite the enormous human and financial burden these conditions create, countries in the Organization for Economic Co-Operation and Development allocate, on average, only around 3 percent of total health expenditure to prevention, based on a 2025 report.
The result is a healthcare model that remains overwhelmingly reactive. Systems spend the majority of their resources treating illness after it occurs, rather than addressing the factors that cause it.
As populations age and chronic diseases continue to rise, this approach is becoming increasingly unsustainable.
Saudi Arabia understands this challenge better than most.
The Kingdom faces a significant burden from non-communicable diseases, including cardiovascular disease, diabetes, cancer and chronic respiratory conditions that account for approximately 73 percent of all deaths, according to a 2020 report by the World Health Organization.
These conditions affect not only individual health outcomes but also workforce productivity, healthcare expenditure and broader economic performance.
Addressing them requires more than expanding treatment capacity. It requires creating environments that support healthier behaviors, encouraging early intervention and building systems capable of identifying risks before they become costly medical conditions.
This is precisely where preventive healthcare delivers value. The most immediate benefit is, of course, improved quality of life. Effective prevention helps people live longer, healthier and more productive lives.
It reduces avoidable suffering, lowers rates of disability and allows individuals to participate more fully in their communities and the economy.
But the economic argument is equally compelling.
A healthier population creates a more productive workforce. It reduces absenteeism, supports labor force participation and lowers the long-term financial burden associated with chronic disease management.
It also contributes to stronger public finances by helping contain healthcare costs that would otherwise continue to rise.
In an increasingly competitive global economy, population health is becoming a critical component of national competitiveness.
Investors, multinational companies and highly skilled professionals increasingly evaluate countries not only on infrastructure and economic indicators, but also on quality of life, healthcare access and long-term sustainability.
Countries that invest in prevention create more resilient economies and stronger foundations for future growth.
This is one reason why Saudi Arabia’s preventive health agenda deserves attention beyond the healthcare sector.
Initiatives promoting healthier lifestyles, expanded screening programs, digital health capabilities and greater public awareness are helping shift the conversation from treatment to prevention.
These efforts align closely with Vision 2030’s broader ambition to improve quality of life while creating a healthier, more productive society.
Yet despite growing momentum globally, one challenge remains.
While governments can measure healthcare spending, hospital capacity and clinical outcomes, there is still no universally accepted way to assess whether countries are truly prepared to prevent future health burdens.
This measurement gap matters.
As highlighted in FTI Consulting’s recent whitepaper, “Silent Systems, Loud Burden,” developed in collaboration with the Future Investment Initiative, health systems often struggle to prioritize prevention because the benefits are dispersed, long-term and difficult to quantify.
Policymakers, investors and health leaders lack a consistent framework for understanding which systems are genuinely equipped to prevent disease and which remain primarily reactive.
That is why we believe the next evolution of preventive healthcare requires something new: a global Preventive Health Readiness Index.
Such an index would provide a structured, transparent and comparable assessment of how effectively countries are building the foundations of prevention.
It would examine critical dimensions such as policy and governance, funding and incentives, digital infrastructure, access and capacity, alongside health outcomes and impact.
Most importantly, it would help turn prevention from an aspiration into a measurable capability.
For governments, it would identify strengths, vulnerabilities and priority areas for investment.
For investors, it would provide greater visibility into markets that are building long-term health resilience. For healthcare leaders, it would create accountability and encourage continuous improvement.
Ultimately, the most successful healthcare systems of the future will not be those that build the largest hospitals. They will be those that create the healthiest societies.
• Oussama Nicolas and Tara Makarem are senior managing directors, Middle East Healthcare & Life Sciences Practice at FTI Consulting.
